CK2 represents a serine/threonine kinase that mediates proliferation-promoting, anti-apoptotic, and thus survival-promoting effects in cancer cells and has likewise been characterized as a regulator of angiogenesis (for review see [3,4]). Here, MARK2 is linked to cancer.